Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celsion refiles for an FDA Special Protocol Assessment for phase III trial of ThermoDox

Dec. 13, 2007

BioInvent designates BI-505 for blood cancer as new drug candidate

Dec. 13, 2007

BioCancell reports successful experimental treatment using BC-819 for ovarian cancer

Dec. 13, 2007

Bv8 promotes tumor growth through angiogenesis

Dec. 13, 2007

Carfilzomib well tolerated in consecutive-day schedule in hematologic malignancies

Dec. 13, 2007

SymBio initiates phase II clinical study of bendamustine hydrochloride

Dec. 12, 2007

Serenex initiates phase I trial of SNX-5422 for hematological malignancies

Dec. 12, 2007

Mologen submits clinical study application for dSLIM for the treatment of cancer

Dec. 12, 2007

Preclinical activity of OT-304 against chemotherapy-resistant tumors

Dec. 12, 2007

Bcr-Abl(T315I) drug-resistant clones are fully suppressed by combination therapy

Dec. 12, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026